a public good project by the
Synthesis
Company
of California

© 2026

G. Schubert-Fritschle | doi.page

0 works0 citations0 h-index

G. Schubert-Fritschle

Zimmer Biomet (Germany)(DE)Ludwig-Maximilians-Universität München(DE)

Publications by Year

Research Areas

Global Cancer Incidence and Screening, Breast Cancer Treatment Studies, Economic and Financial Impacts of Cancer, Cutaneous Melanoma Detection and Management, Lung Cancer Treatments and Mutations

Most-Cited Works

→ Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study(2017)481 cited
→ Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study(2015)477 cited
→ Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study(2015)275 cited
→ The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries(2015)255 cited
→ Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5(2015)176 cited
→ Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care(2017)150 cited

→ Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5(2015)148 cited

→ Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate(2002)146 cited

→ On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 study(2015)122 cited

→ The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods(2015)122 cited